- Trials with a EudraCT protocol (261)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
261 result(s) found for: Acute kidney failure.
Displaying page 1 of 14.
EudraCT Number: 2016-004361-12 | Sponsor Protocol Number: FER-CIT-2016-01 | Start Date*: 2017-03-27 | ||||||||||||||||
Sponsor Name:Fernando Sánchez | ||||||||||||||||||
Full Title: Oxidative stress and extracellular nucleosomes in critically ill patients with acute kidney failure treated with continuous renal replacement therapies. Effect of two anticoagulation strategies of ... | ||||||||||||||||||
Medical condition: Acute renal failure (ARF). | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-018553-35 | Sponsor Protocol Number: SMF1482 | Start Date*: 2010-05-03 | |||||||||||
Sponsor Name:Gambro Lundia AB | |||||||||||||
Full Title: SMARTCIT - A NOVEL CITRATE BASED ANTICOAGULATION | |||||||||||||
Medical condition: Acute renal failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002077-12 | Sponsor Protocol Number: MR-2008/001 | Start Date*: 2008-09-24 | |||||||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI PERUGIA | |||||||||||||||||||||||
Full Title: Fenoldopam end Renal failure (FENO-HSR) | |||||||||||||||||||||||
Medical condition: Renal failure from ipoperfusion post Cardiac surgery | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004426-24 | Sponsor Protocol Number: 951/07 | Start Date*: 2007-07-06 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: PROSTACYCLIJN VERSUS HEPARIN AS ANTICOAGULANT IN CONTINUOUS VENO-VENOUS HEMODIAFILTRATION | |||||||||||||
Medical condition: Acute renale failure in intensive unit | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007132-25 | Sponsor Protocol Number: AS-CD-04 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:EBI Anti Sepsis B.V. | |||||||||||||
Full Title: A randomized, double blind, parallel, placebo controlled, exploratory study to assess the effect of EA-230 on renal function and on safety and tolerability in patients at increased risk of developi... | |||||||||||||
Medical condition: acute renal failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002109-32 | Sponsor Protocol Number: CORL2007 | Start Date*: 2007-05-10 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO | |||||||||||||
Full Title: USE OF FENOLDOPAM TO IMPROVE GLOMERULAR FILTRATION RATE IN EARLY RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION | |||||||||||||
Medical condition: Adult liver transplanted patients age > 18 years , with pre-transplantation normal renal function creatinine clearance 1ml/kg/min | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014562-26 | Sponsor Protocol Number: CERL080AES08 | Start Date*: 2010-02-17 | ||||||||||||||||
Sponsor Name:Novartis Farmacéuitica S.A | ||||||||||||||||||
Full Title: Estudio multicéntrico, aleatorizado, abierto de maximización de micofenolato sódico (MFS) versus micofenolato mofetilo (MMF) para minimizar la dosis de tacrolimus en pacientes trasplantados renale... | ||||||||||||||||||
Medical condition: Profilaxis del rechazo agudo en trasplante alogénico renal. Minimizar la dosis de tacrolimus en pacientes trasplantados renales en mantenimiento | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-000304-41 | Sponsor Protocol Number: FG-506E-12-03 | Start Date*: 2004-12-15 | |||||||||||
Sponsor Name:Astellas Pharma GmbH | |||||||||||||
Full Title: A MULTICENTRE, 1:1 RANDOMISED, DOUBLE BLIND, TWO ARM PARALLEL GROUP STUDY TO EVALUATE AND COMPARE THE EFFICACY AND SAFETY OF MODIFIED RELEASE TACROLIMUS FK506E (MR4) VERSUS TACROLIMUS FK506 IN COMB... | |||||||||||||
Medical condition: Patients with end stage kidney disease who will undergo renal transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) SE (Completed) HU (Completed) FI (Completed) AT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004979-39 | Sponsor Protocol Number: 8.1 | Start Date*: 2014-12-19 |
Sponsor Name:VieCuri Medical Center | ||
Full Title: Levosimendan in Acute Kidney Injury Study, a prospective, randomized, monocenter, double blind, placebo-controlled study to investigate the efficacy and safety of Levosimendan in Intensive Care Pat... | ||
Medical condition: Acute Kidney Injury (AKI) in adult ICU patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006014-20 | Sponsor Protocol Number: FARM6X822T | Start Date*: 2009-01-19 | |||||||||||
Sponsor Name:CONSORZIO MARIO NEGRI SUD | |||||||||||||
Full Title: Effects of the dose of erythropoiesis stimulating agents on cardiac-cerebrovascular outcomes and quality of life in hemodialysis patients. The DOSe of Erythropoietins (DOSE) trial. | |||||||||||||
Medical condition: End stage kidney disease and anemia, treated with hemodialysis for renal replacement therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001407-11 | Sponsor Protocol Number: Certican MHH PRTx01 | Start Date*: 2006-07-18 | |||||||||||
Sponsor Name:Medizinische Hochschule Hannover | |||||||||||||
Full Title: A single center study investigating ciclosporine A microemulsion in combination with basiliximab and prednisolon and switch to low-dose ciclosporine A and everolimus without steroids in the prevent... | |||||||||||||
Medical condition: Kidney transplantation after end stage renal failure | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000796-32 | Sponsor Protocol Number: 185/13 | Start Date*: 2014-01-28 | |||||||||||
Sponsor Name:Policlinico A. Gemelli | |||||||||||||
Full Title: A multiple centre, randomised, open label, prospective clinical study to compare the efficacy and safety of a combination of tacrolimus with everolimus versus the combination of tacrolimus with MM... | |||||||||||||
Medical condition: KIDNEY TRANSPLANTATION | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003968-22 | Sponsor Protocol Number: ETFLCHD01 | Start Date*: 2008-02-04 | ||||||||||||||||||||||||||
Sponsor Name:University Hospital Birmingham | ||||||||||||||||||||||||||||
Full Title: European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy | ||||||||||||||||||||||||||||
Medical condition: Multiple myeloma patients with acute dialysis dependent renal failure resulting from cast nephropathy. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (Completed) DE (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003866-16 | Sponsor Protocol Number: AP REN 01-01 | Start Date*: 2009-03-03 | ||||||||||||||||
Sponsor Name:AM-Pharma B.V. | ||||||||||||||||||
Full Title: A Phase-II, double-blind, randomized, placebo-controlled proof of concept study on the safety and early efficacy of Alkaline Phosphatase in sepsis patients with Renal Failure. | ||||||||||||||||||
Medical condition: Sepsis with Renal Failure | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-016801-40 | Sponsor Protocol Number: IP-001-09 | Start Date*: 2016-01-26 | |||||||||||
Sponsor Name:IPERBOREAL PHARMA | |||||||||||||
Full Title: Efficacy and Safety assessments of a peritoneal dialysis solution containing Glucose, Xylitol and L-Carnitine compared to standard PD solutions in Continuous Ambulatory Peritoneal Dialysis (CAPD) | |||||||||||||
Medical condition: Patients with ESRD treated by CAPD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001520-18 | Sponsor Protocol Number: NL76839.042.21 | Start Date*: 2021-04-09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:RECOVAC consortium | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Long term efficacy and safety of SARS-CoV-2 vaccination in Dutch patients with chronic kidney disease stage G4-G5, on dialysis or after kidney transplantation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: COVID-19 is associated with increased morbidity and mortality in kidney transplant recipients (KTR) and patients with chronic kidneydisease (CKD). Therefore, potential efficacious SARS-CoV-2 vaccin... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-000644-16 | Sponsor Protocol Number: Dor1.0 | Start Date*: 2011-05-03 | |||||||||||||||||||||
Sponsor Name:University of Tartu, Clinic of Anaesthesiology and Intensive Care | |||||||||||||||||||||||
Full Title: High volume haemodiafiltration in treatment of severe sepsis -- impact on pharmacokinetics of doripenem and piperacillin tazobactam and inflammatory response | |||||||||||||||||||||||
Medical condition: adult intensive care patient with severe sepsis or septic shock and acute renal failure requiring renal replacement therapy | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: EE (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-000033-19 | Sponsor Protocol Number: 4xmmf | Start Date*: 2007-06-05 | |||||||||||||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||||||||||||
Full Title: An open study to investigate the effect of 4 instead of 2 daily dosing mycophenolate mofetil (MMF) in renal transplant patients on diarrhea | |||||||||||||||||||||||
Medical condition: Diarrhea in renal transplanted patients which use Cellcept® | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001043-39 | Sponsor Protocol Number: ML17225 | Start Date*: 2016-10-03 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche AG | |||||||||||||
Full Title: An Open-Label, Prospective, Randomized, Controlled, Multi-Center Study Assessing Fixed Dose Vs Concentration Controlled Cellcept Regimens For Patients Following A Single Organ Renal Transplantation... | |||||||||||||
Medical condition: Renal Transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004223-12 | Sponsor Protocol Number: CT-1KIDN-01 | Start Date*: 2012-08-27 | |||||||||||
Sponsor Name:Digna Biotech S.L. | |||||||||||||
Full Title: A pilot, randomised, double blind, placebo-controlled, parallel groups, clinical trial to investigate the efficacy and safety of Cardiotrophin-1 (CT-1) in kidney transplantation. | |||||||||||||
Medical condition: Kidney transplantation. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
